Format:
12
,
Illustrationen
ISSN:
2072-6694
Content:
Patients suffering from metastasized melanoma can be treated with three different combinations of tablets (“targeted therapy”), with similar efficacy but different side effect profiles. When one of the combinations is not tolerated well, their physicians may switch to a different combination; however, it has not been evaluated whether the second combination is actually tolerated better. ...
Note:
Gesehen am 07.12.2023
In:
Cancers, Basel : MDPI, 2009, 15(2023), 5, Artikel-ID 1426, Seite 1-12, 2072-6694
In:
volume:15
In:
year:2023
In:
number:5
In:
elocationid:1426
In:
pages:1-12
In:
extent:12
Language:
English
DOI:
10.3390/cancers15051426
URL:
Volltext
(kostenfrei)
URL:
Volltext
(kostenfrei)
Bookmarklink